Selecta Bio up 21% ahead of Q4 report Mar. 8, 2019 10:36 AM ET|About: Selecta Biosciences (SELB)|By: Douglas W. House, SA News Editor Micro cap Selecta Biosciences (SELB +21.2%) is up on a 4x surge in volume ahead of its Q4 and 2018 report before the open on March 15.
The surge in buying appears to be rippling from fellow tiny biotech Bio-Path Holdings which rocketed as high as 40-fold in about a week before retracing in response to positive data on prexigebersen.